-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Raymond James & Associates Purchases 3,300 Shares of Cerus Co. (NASDAQ:CERS)
Raymond James & Associates Purchases 3,300 Shares of Cerus Co. (NASDAQ:CERS)
Raymond James & Associates boosted its position in Cerus Co. (NASDAQ:CERS – Get Rating) by 0.3% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,276,057 shares of the biotechnology company's stock after purchasing an additional 3,300 shares during the quarter. Raymond James & Associates owned approximately 0.72% of Cerus worth $7,006,000 at the end of the most recent reporting period.
Other large investors have also added to or reduced their stakes in the company. MQS Management LLC bought a new position in Cerus in the fourth quarter worth about $69,000. WMS Partners LLC bought a new position in Cerus in the fourth quarter worth about $75,000. KBC Group NV bought a new position in Cerus in the first quarter worth about $83,000. Csenge Advisory Group bought a new position in Cerus in the first quarter worth about $86,000. Finally, Gotham Asset Management LLC bought a new position in Cerus in the fourth quarter worth about $109,000. 84.72% of the stock is currently owned by institutional investors.
Get Cerus alerts:Insider Transactions at Cerus
In other news, insider Richard J. Benjamin sold 10,000 shares of the business's stock in a transaction dated Tuesday, August 9th. The stock was sold at an average price of $5.12, for a total transaction of $51,200.00. Following the sale, the insider now owns 172,665 shares in the company, valued at $884,044.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 7.33% of the company's stock.
Cerus Stock Performance
Shares of Cerus stock opened at $3.92 on Friday. Cerus Co. has a one year low of $3.90 and a one year high of $8.06. The company has a market capitalization of $694.19 million, a PE ratio of -16.33 and a beta of 1.07. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.73 and a current ratio of 2.08. The company has a 50-day simple moving average of $5.25 and a two-hundred day simple moving average of $5.19.Cerus Profile
(Get Rating)
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.
Featured Stories
- Get a free copy of the StockNews.com research report on Cerus (CERS)
- Could Snap Stock Rebound As Management Restructures?
- MarketBeat: Week in Review 8/29 – 9/2
- Hormel Looks Cheap At These Levels
- Lululemon Set To Soar Into September
- Could Nike Stock be Oversold, but Still Overvalued?
Receive News & Ratings for Cerus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerus and related companies with MarketBeat.com's FREE daily email newsletter.
Raymond James & Associates boosted its position in Cerus Co. (NASDAQ:CERS – Get Rating) by 0.3% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,276,057 shares of the biotechnology company's stock after purchasing an additional 3,300 shares during the quarter. Raymond James & Associates owned approximately 0.72% of Cerus worth $7,006,000 at the end of the most recent reporting period.
据Raymond James&Associates提交给美国证券交易委员会的最新Form 13F文件显示,该公司今年第一季度将其在Cerus Co.(股票代码:CERS-GET Rating)的持仓提高了0.3%。该机构投资者在本季度额外购买了3300股后,持有这家生物技术公司1,276,057股股票。在最近一个报告期结束时,Raymond James&Associates拥有Cerus约0.72%的股份,价值7,006,000美元。
Other large investors have also added to or reduced their stakes in the company. MQS Management LLC bought a new position in Cerus in the fourth quarter worth about $69,000. WMS Partners LLC bought a new position in Cerus in the fourth quarter worth about $75,000. KBC Group NV bought a new position in Cerus in the first quarter worth about $83,000. Csenge Advisory Group bought a new position in Cerus in the first quarter worth about $86,000. Finally, Gotham Asset Management LLC bought a new position in Cerus in the fourth quarter worth about $109,000. 84.72% of the stock is currently owned by institutional investors.
其他大型投资者也增持或减持了该公司的股份。MQS Management LLC在第四季度购买了Cerus的一个新头寸,价值约6.9万美元。WMS Partners LLC在第四季度购买了Cerus的一个新头寸,价值约7.5万美元。KBC Group NV在第一季度购买了Cerus的一个新头寸,价值约83,000美元。Csenge Consulting Group在第一季度购买了Cerus的一个新头寸,价值约8.6万美元。最后,Gotham Asset Management LLC在第四季度购买了Cerus的一个新头寸,价值约10.9万美元。84.72%的股票目前由机构投资者持有。
Insider Transactions at Cerus
Cerus的内幕交易
In other news, insider Richard J. Benjamin sold 10,000 shares of the business's stock in a transaction dated Tuesday, August 9th. The stock was sold at an average price of $5.12, for a total transaction of $51,200.00. Following the sale, the insider now owns 172,665 shares in the company, valued at $884,044.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 7.33% of the company's stock.
另一则消息是,内部人士理查德·J·本杰明在一笔日期为8月9日(星期二)的交易中出售了10,000股该公司股票。该股以5.12美元的平均价格出售,总成交金额为51,200.00美元。出售后,这位内部人士现在拥有该公司172,665股,价值884,044.80美元。这笔交易是在提交给美国证券交易委员会的一份法律文件中披露的,该文件可以通过这个超级链接获得。内部人士持有该公司7.33%的股份。
Cerus Stock Performance
Cerus股票表现
Cerus Profile
CERUS轮廓
(Get Rating)
(获取评级)
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.
Cerus公司是一家生物医药产品公司。该公司专注于开发拦截血液系统并将其商业化,以增强血液安全。其拦截血液系统,这是一项控制生物复制的专利技术,旨在减少用于输血的捐献血液成分中的血源性病原体。
Featured Stories
专题报道
- Get a free copy of the StockNews.com research report on Cerus (CERS)
- Could Snap Stock Rebound As Management Restructures?
- MarketBeat: Week in Review 8/29 – 9/2
- Hormel Looks Cheap At These Levels
- Lululemon Set To Soar Into September
- Could Nike Stock be Oversold, but Still Overvalued?
- 免费获取StockNews.com关于Cerus的研究报告(CERS)
- 随着管理层重组,股市能否迅速反弹?
- MarketBeat:回顾中的一周8/29-9/2
- 霍梅尔在这些水平上看起来很便宜
- 露露柠檬将飙升至9月
- 耐克股票会被超卖,但仍被高估吗?
Receive News & Ratings for Cerus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerus and related companies with MarketBeat.com's FREE daily email newsletter.
接受《Cerus Daily》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Cerus和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧